日本ゲノム編集学会

Keystone Symposia Conference on “Genome Engineering: From Mechanisms to Therapies”

Submit an abstract and register today for Keystone Symposia’s upcoming conference on “Genome Engineering: From Mechanisms to Therapies” scheduled for February 19-23, 2019 at the Fairmont Empress Victoria in Victoria, British Columbia, Canada.

Organized by Drs. Andrew May of the Chan Zuckerberg Biohub, Rodolphe Barrangou of North Carolina State University and Knut Woltjen of CiRA, Kyoto University, the four-day conference will:
1)Provide a comprehensive overview of the applications of genome engineering toward the development of human therapeutics;
2)Discuss the integration of current technologies for modifying genomes through direct engineering and epigenome manipulation in both prokaryotic and eukaryotic cells;
3)Cover the current status of genome engineering clinical trials and highlight outstanding challenges that remain for the successful translation of basic research to disease treatment.

Scholarships, requiring submission of an abstract, are available to graduate students and postdoctoral fellows from any nation. Short talk speakers will be chosen from all abstracts submitted by the abstract deadline.

Deadlines:
•Scholarship Applications and Discounted Abstract – October 23, 2018
•Abstract – November 20, 2018
•Discounted Registration – December 19, 2018

For more information, please visit www.keystonesymposia.org/19B4
For a flyer, please visit http://www.keystonesymposia.org/index.cfm?e=Web.Meeting.Flyer&MeetingID=1616 to download.

Hashtag for this meeting: #KSgenomeeng

賛助会員

  • (株)島津製作所

    (株)島津製作所のサイトへ移動します
  • ネッパジーン(株)

    ネッパジーン(株)のサイトへ移動します
  • エディットフォース(株)

    エディットフォース(株)のサイトへ移動します
  • 富士フイルム和光純薬

    富士フイルム和光純薬(株)のサイトへ移動します
  • 246_charles_river

    日本チャールス・リバー(株)のサイトへ移動します